Emerald Mutual Fund Advisers Trust Travere Therapeutics, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.47 Billion
- Q2 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 1,141,428 shares of TVTX stock, worth $29.9 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
1,141,428
Previous 1,121,886
1.74%
Holding current value
$29.9 Million
Previous $20.1 Million
15.97%
% of portfolio
1.15%
Previous 1.63%
Shares
8 transactions
Others Institutions Holding TVTX
# of Institutions
230Shares Held
101MCall Options Held
1.71MPut Options Held
401K-
Janus Henderson Group PLC London, X09.54MShares$250 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$233 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$157 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C35.1MShares$134 Million0.1% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.68B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...